Quantcast
Last updated on April 20, 2014 at 14:04 EDT

Latest Anticonvulsants Stories

2013-05-01 08:32:06

Two Research Abstracts Accepted for the International Society for Pharmacoeconomics and Outcomes Research 18th Annual International Meeting BOWIE, Md., May 1, 2013 /PRNewswire/ -- Inovalon, Inc., a leading provider of data-driven healthcare solutions, today announced two comparative effectiveness research studies to be presented at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18(th) Annual International Meeting May 18-22 in New Orleans, La. The...

2013-04-30 08:35:12

Klitgaard to be Honored at Antiepileptic Drug and Device Trials XII Conference in Miami May 15-17 LANDOVER, Md., April 30, 2013 /PRNewswire-USNewswire/ -- The Epilepsy Foundation announced today that Henrik Klitgaard, Ph.D., Vice President and Fellow, Neurosciences Therapeutic Area, UCB, has been named the recipient of the Epilepsy Therapy Project Lifetime Accelerator Award in recognition of his commitment and contributions to the field of epilepsy and to the people affected by it....

2013-04-24 12:35:59

Maternal use of valproate (a drug used for the treatment of epilepsy and other neuropsychological disorders) during pregnancy was associated with a significantly increased risk of autism in offspring, according to a study in the April 24 issue of JAMA. The authors caution that these findings must be balanced against the treatment benefits for women who require valproate for epilepsy control. "Anti-epileptic drug exposure during pregnancy has been associated with an increased risk for...

2013-04-12 23:01:46

A new study published on March 6th, 2013 in the journal Acta Neurologica Scandinavica revealed that valproate (Depakote) is linked with birth defects. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) April 12, 2013 AttorneyOne.com, a recognized authority on law, updated the website recently and is now...

2013-04-09 12:27:26

Greater Reduction in Pain Intensity is One of the Greatest Unmet Needs in Postherpetic Neuralgia, According to a New Report from Decision Resources BURLINGTON, Mass., April 9, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that surveyed U.S. and European neurologists agree that reduction in pain intensity is one of the attributes that most influences their decisions regarding prescribing...

2013-03-23 23:02:58

If you or anyone you know has taken Topamax during a pregnancy, the attorneys at d'Oliveira & Associates urge you to contact them immediately. (PRWEB) March 23, 2013 Topamax is a popular anticonvulsant prescription drug manufactured by the Johnson & Johnson subsidiary Ortho-McNeil Pharmaceutical. Originally approved by The U.S. Food and Drug Administration (FDA) in 1996 to treat persons experiencing epileptic seizures, the drug has since been approved as an anti-migraine drug and...

2013-03-05 08:30:51

-- Top-line results demonstrate that the conversion to lacosamide monotherapy study met its primary endpoint ATLANTA and BRUSSELS, March 5, 2013 /PRNewswire/ -- regulated information - UCB today announced positive results of a Phase 3 study designed to evaluate the efficacy and safety of conversion to lacosamide monotherapy in adult patients with partial-onset seizures with or without secondary generalization compared with a historical control. The study met its primary endpoint...

2013-01-26 23:04:54

On January 23rd 2013, the Lancet Neurology published the results of a new study revealing that children of mothers who take valproate (incl. Depakote) during pregnancy have lower IQ scores at age 6. In light of this news, AttorneyOne, a recognized authority on law, informs that they are now providing advice, including how to get in contact with legal counsel, to people potentially affected by Depakote side effects. San Diego, CA (PRWEB) January 25, 2013 AttorneyOne.com, a recognized...

2013-01-08 12:25:30

PARSIPPANY, N.J. and MUMBAI, India, Jan. 8, 2013 /PRNewswire/ -- Pharmaceutical and biotechnology major Wockhardt has received final approval from the United States Food & Drug Administration (US FDA) for marketing 25mg, 50mg, 100mg, 200mg and 300mg extended release tablets of Lamotrigine, which is used in treatment of epilepsy. Lamotrigine is the generic name for the brand Lamictal XR®, marketed in the United States by Glaxo SmithKline. Wockhardt is launching the product immediately...

2012-12-28 12:22:34

PITTSBURGH, Dec. 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its subsidiary Mylan Pharmaceuticals Inc. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Phenytoin Chewable Tablets USP, 50 mg. This product is the generic version of Pfizer's Dilantin® Chewable Tablets, which are indicated for the control of generalized tonic-clonic (grand mal) and complex partial (psychomotor, temporal...